Validation of Next Generation Sequencing-Based Clonality Assays for Diagnosis and Minimal Residual Disease Tracking in Lymphoid Malignancies

被引：0
|
作者：
Wu, Haiyan [1 ]
Li, Feng [1 ]
Cai, Jiacheng [1 ]
Zhang, Ke [1 ]
Zheng, Xin [1 ]
Yao, Jicheng [1 ]
Wang, Weifeng [1 ]
Wang, Kai [1 ]
机构：
[1] OrigiMed Co Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-150151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Minimal Residual Disease Detection of Lymphoid and Plasma Cell Neoplasms Using a Next-Generation Sequencing (NGS)-Based Assay
    Ho, C.
    Gomez-Gelvez, J. C.
    Syed, M. H.
    Zehir, A.
    Yu, W.
    Baldi, T.
    Ladanyi, M.
    Dugan, A.
    Yao, J.
    Nafa, K.
    Arcila, M. E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 961 - 962
  • [22] Next-Generation Sequencing-Based Detection of Gene Fusions in Hematologic Malignancies
    Partain, J. D.
    Yang, F.
    Press, R. D.
    Wang, Y.
    Trifilo, K.
    Johnson, L. A.
    Kudlow, B. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 958 - 959
  • [23] Clinical utility of next-generation sequencing-based minimal residual disease in paediatric B-cell acute lymphoblastic leukaemia
    Sekiya, Yuko
    Xu, Yinyan
    Muramatsu, Hideki
    Okuno, Yusuke
    Narita, Atsushi
    Suzuki, Kyogo
    Wang, Xinan
    Kawashima, Nozomu
    Sakaguchi, Hirotoshi
    Yoshida, Nao
    Hama, Asahito
    Takahashi, Yoshiyuki
    Kato, Koji
    Kojima, Seiji
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (02) : 248 - 257
  • [24] A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations
    Levis, Mark J.
    Perl, Alexander E.
    Altman, Jessica K.
    Gocke, Christopher D.
    Bahceci, Erkut
    Hill, Jason
    Liu, Chaofeng
    Xie, Zhiyi
    Carson, Andrew R.
    McClain, Valerie
    Stenzel, Timothy T.
    Miller, Jeffrey E.
    BLOOD ADVANCES, 2018, 2 (08) : 825 - 831
  • [25] Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements A Multicenter Validation Study by EuroClonality-NGS
    van den Brand, Michiel
    Rijntjes, Jos
    Mobs, Markus
    Steinhilber, Julia
    van der Klift, Michele Y.
    Heezen, Kim C.
    Kroeze, Leonie I.
    Reigl, Tomas
    Porc, Jakub
    Darzentas, Nikos
    Luijks, Jeroen A. C. W.
    Scheijen, Blanca
    Davi, Frederic
    ElDaly, Hesham
    Liu, Hongxiang
    Anagnostopoulos, Ioannis
    Hummel, Michael
    Fend, Falko
    Langerak, Anton W.
    Groenen, Patricia J. T. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2021, 23 (09): : 1105 - 1115
  • [26] A Novel Approach to Next-Generation Sequencing-Based Assessment of T-cell Clonality
    Oldridge, D. A.
    Gentile, C.
    Rosenbaum, J. N.
    Van Deerlin, V. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1245 - 1246
  • [27] Next-generation sequencing for measuring minimal residual disease in AML
    Walter, Roland B.
    Appelbaum, Frederick R.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (08) : 473 - 474
  • [28] Detection of minimal residual disease by next generation sequencing in AL amyloidosis
    Sarosiek, Shayna
    Varga, Cindy
    Jacob, Allison
    Fulciniti, Maria Teresa
    Munshi, Nikhil
    Sanchorawala, Vaishali
    BLOOD CANCER JOURNAL, 2021, 11 (06)
  • [29] Detection of minimal residual disease by next generation sequencing in AL amyloidosis
    Shayna Sarosiek
    Cindy Varga
    Allison Jacob
    Maria Teresa Fulciniti
    Nikhil Munshi
    Vaishali Sanchorawala
    Blood Cancer Journal, 11
  • [30] Next-generation sequencing for measuring minimal residual disease in AML
    Roland B. Walter
    Frederick R. Appelbaum
    Nature Reviews Clinical Oncology, 2018, 15 : 473 - 474
12345